{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:09Z","timestamp":1759047009876,"version":"3.44.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012651","name":"College of Veterinary Medicine, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vetimm.2023.110560","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T01:57:24Z","timestamp":1676253444000},"page":"110560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Characterization of expression and prognostic implications of transforming\u00a0growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma"],"prefix":"10.1016","volume":"257","author":[{"given":"Jacqueline D.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keijiro","family":"Shiomitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan J.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Ossiboff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessy Castellanos","family":"Gell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Axiak-Bechtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2023.110560_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-019-0779-5","article-title":"Immune checkpoint inhibitors of PD-L1 as cancer therapeutics","volume":"12","author":"Akinleye","year":"2019","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/0300985815575050","article-title":"Growth factors and COX2 expression in canine perivascular wall tumors","volume":"52","author":"Avallone","year":"2015","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110560_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.17221\/7\/2015-VETMED","article-title":"Changes in regulatory T cells in dogs with B-cell lymphoma and association with clinical tumour stage","volume":"62","author":"Baek","year":"2017","journal-title":"Veter Med."},{"key":"10.1016\/j.vetimm.2023.110560_bib4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.2438","article-title":"Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido","volume":"17","author":"Balachandran","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.vetimm.2023.110560_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1939-1676.2010.0557.x","article-title":"Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma: CD8:treg in canine osteosarcoma","volume":"24","author":"Biller","year":"2010","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2023.110560_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jsap.12354","article-title":"Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma","volume":"56","author":"Cannon","year":"2015","journal-title":"J. Small Anim. Pr."},{"key":"10.1016\/j.vetimm.2023.110560_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207619","article-title":"A method for manual and automated multiplex RNAscope\u00ae in situ hybridization and immunocytochemistry on cytospin samples","volume":"13","author":"Chan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2023.110560_bib8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/jcp.29108","article-title":"Transforming growth factor \u03b2 signaling pathway: a promising therapeutic target for cancer","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.vetimm.2023.110560_bib9","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.3390\/ijms22147575","article-title":"TGF-\u03b2 signaling: from tissue fibrosis to tumor microenvironment","volume":"22","author":"Chung","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.vetimm.2023.110560_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1354\/vp.39-1-66","article-title":"The diagnosis and prognosis of synovial tumors in dogs: 35 cases","volume":"39","author":"Craig","year":"2002","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110560_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/cancers10060194","article-title":"TGF-\u03b2 in T cell biology: implications for cancer immunotherapy","volume":"10","author":"Dahmani","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.vetimm.2023.110560_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00262-014-1581-4","article-title":"Foxp3 expression in T regulatory cells and other cell lineages","volume":"63","author":"Devaud","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.vetimm.2023.110560_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-2427(01)00337-3","article-title":"Lymphocyte subsets in peripheral blood of dogs \u2014 a flow cytometric study","volume":"82","author":"Faldyna","year":"2001","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2023.110560_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5810.2006.00090.x","article-title":"Histiocytic sarcomas in flat-coated retrievers: a summary of 37 cases (November 1998-March 2005)","volume":"4","author":"Fidel","year":"2006","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib15","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.vetimm.2023.110560_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/vco.12197","article-title":"Immune regulation of canine tumour and macrophage PD-L1 expression: Regulation of canine PD-L1 expression","volume":"15","author":"Hartley","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4049\/jimmunol.172.3.1508","article-title":"Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-\u03b21 and restores the lymphokine-activated killing activity","volume":"172","author":"Hsiao","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2023.110560_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111046","article-title":"Recent progress in TGF-\u03b2 inhibitors for cancer therapy","volume":"134","author":"Huang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.vetimm.2023.110560_bib20","first-page":"7","article-title":"Clinical potential of regulatory T cell therapy in liver diseases: an overview and current perspectives","author":"Jeffery","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110560_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00262-015-1684-6","article-title":"Crosstalk of carcinoembryonic antigen and transforming growth factor-\u03b2 via their receptors: comparing human and canine cancer","volume":"64","author":"Jensen-Jarolim","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.vetimm.2023.110560_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.vetimm.2023.110560_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2023.110560_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/vco.12314","article-title":"Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs","volume":"16","author":"Kezer","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","article-title":"Novel therapies emerging in oncology to target the TGF-\u03b2 pathway","volume":"14","author":"Kim","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib26","doi-asserted-by":"crossref","first-page":"18994","DOI":"10.1038\/s41598-020-76130-1","article-title":"Regulatory (FoxP3+) T cells and TGF-\u03b2 predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer","volume":"10","author":"Koh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2023.110560_bib27","article-title":"The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells","author":"Laba","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.vetimm.2023.110560_bib28","first-page":"12","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","author":"Liu","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.vetimm.2023.110560_bib29","first-page":"11","article-title":"Immunohistochemical analysis of PD-L1 expression in canine malignant cancers and PD-1 expression on lymphocytes in canine oral melanoma","author":"Maekawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2023.110560_bib30","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1038\/s41598-017-09444-2","article-title":"A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma","volume":"7","author":"Maekawa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2023.110560_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0300985817690208","article-title":"T lymphocytes in histiocytic sarcomas of flat-coated retriever dogs","volume":"54","author":"Marcinowska","year":"2017","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110560_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/vco.12609","article-title":"Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: an Italian Society of Veterinary Oncology study","volume":"18","author":"Marconato","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/vco.12437","article-title":"Primary pulmonary histiocytic sarcoma in dogs: a retrospective analysis of 37 cases (2000-2015)","volume":"16","author":"Marlowe","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib34","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1111\/vco.12329","article-title":"Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy","volume":"16","author":"Mason","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0300985813510413","article-title":"A review of histiocytic diseases of dogs and cats","volume":"51","author":"Moore","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110560_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2014.11.001","article-title":"Targeting the TGF\u03b2 pathway for cancer therapy","volume":"147","author":"Neuzillet","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vetimm.2023.110560_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/ijo.2015.2816","article-title":"Role of TGF\u03b2 in regulation of the tumor microenvironment and drug delivery (review)","volume":"46","author":"Papageorgis","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2567.2010.03346.x","article-title":"Phenotypic and functional characterization of a CD4+ CD25high FOXP3high regulatory T-cell population in the dog","volume":"132","author":"Pinheiro","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.vetimm.2023.110560_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-cancerbio-030419-033428","article-title":"Regulatory T cells in cancer","volume":"4","author":"Plitas","year":"2020","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.vetimm.2023.110560_bib40","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/jvim.12348","article-title":"Pro\u2010tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma","volume":"28","author":"Portela","year":"2014","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2023.110560_bib41","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1939-1676.2010.0588.x","article-title":"Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma","volume":"24","author":"Rassnick","year":"2010","journal-title":"J. Vet. Intern. Med"},{"key":"10.1016\/j.vetimm.2023.110560_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00580-017-2410-x","article-title":"Immunohistochemical expression of transforming growth factor Beta-1 in canine mammary carcinomas: its relationships with histologic grading, survival rate, and recurrence","volume":"26","author":"Rezaee","year":"2017","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.vetimm.2023.110560_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/vco.12383","article-title":"Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours","volume":"16","author":"Sakai","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2023.110560_bib45","first-page":"319","article-title":"Molecular diagnosis using RNAscope\u00ae in-situ hybridization in canine malignancies","volume":"84","author":"Shiomitsu","year":"2020","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2023.110560_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"Skorupski","year":"2007","journal-title":"J. Vet. Intern. Med"},{"key":"10.1016\/j.vetimm.2023.110560_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5829.2009.00186.x","article-title":"Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy","volume":"7","author":"Skorupski","year":"2009","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110560_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/10520295.2020.1818826","article-title":"Expression of angiogenic growth factors in canine squamous cell cancers","volume":"96","author":"S\u00f6zmen","year":"2021","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.vetimm.2023.110560_bib49","first-page":"141","article-title":"Immunophenotyping of human regulatory T cells","volume":"vol 2032","author":"Staats","year":"2019"},{"key":"10.1016\/j.vetimm.2023.110560_bib50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and Function of the PD-L1 Checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2023.110560_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5120109","article-title":"Switching roles of TGF-\u03b2 in Cancer development: implications for therapeutic target and biomarker studies","volume":"5","author":"Sun","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vetimm.2023.110560_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.656715","article-title":"Canine transforming growth factor-\u03b2 receptor 2-Ig: a potential candidate biologic for melanoma treatment that reverses transforming growth factor-\u03b21 immunosuppression","volume":"8","author":"Takeuchi","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.vetimm.2023.110560_bib53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jvim.15673","article-title":"Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs","volume":"34","author":"Toyoda","year":"2020","journal-title":"J. Vet. Intern. Med"},{"key":"10.1016\/j.vetimm.2023.110560_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope\u00ae: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.vetimm.2023.110560_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02623551","article-title":"A macrophage-monocyte cell line from a dog with malignant histiocytosis","volume":"24","author":"Wellman","year":"1988","journal-title":"Vitr. Cell. Dev. Biol."},{"key":"10.1016\/j.vetimm.2023.110560_bib56","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2019.02022","article-title":"PD-L1 distribution and perspective for cancer immunotherapy-blockade, knockdown, or inhibition","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110560_bib57","first-page":"12","article-title":"Efficacy of PD-1\/PD-L1 blockade monotherapy in clinical trials","author":"Zhao","year":"2020","journal-title":"Ther. Adv. Med. Oncol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242723000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242723000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:29:52Z","timestamp":1759044592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242723000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":57,"alternative-id":["S0165242723000144"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2023.110560","relation":{},"ISSN":["0165-2427"],"issn-type":[{"type":"print","value":"0165-2427"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of expression and prognostic implications of transforming\u00a0growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2023.110560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110560"}}